Drug resistance against gemcitabine and topotecan mediated by constitutive hsp70 overexpression in vitro: Implication of quercetin as sensitiser in chemotherapy

British Journal of Cancer

Volumn 74, Issue 2, 1996, Pages 172-177

  Sliutz, G ^a   Karlseder, J ^b   Tempfer, C ^a   Orel, L ^b   Holzer, G ^b   Simon, M M ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF NATURAL RESOURCES AND LIFE SCIENCES   (Austria)

Author keywords

Gemcitabine; Heat shock protein; hsp70; Topotecan

Indexed keywords

COMPLEMENTARY DNA; GEMCITABINE; HEAT SHOCK PROTEIN; QUERCETIN; TOPOTECAN; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DRUG RESISTANCE; FIBROSARCOMA; GENE EXPRESSION REGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; SIMIAN VIRUS 40;

EID: 0030016274     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.334     Document Type: Article

References (29)

1. BOUKAMP P, STANBRIDGE EJ, FOO DY, CERUTTI PA AND FUSENIG NE. (1990). c-Ha-ras oncogene expression in immortalized human keratinocytes (HaCaT) alters growth potential in vivo but lacks correlation with malignancy. Cancer Res., 50, 2840-2847.
2. BREITKREUTZ D, BOUKAMP P, RYLE CM, STARK HJ, ROOP DR AND FUSENIG NE. (1991). Epidermal morphogenesis and keratin expression in c-Ha-ras-transfected tumorigenic clones of the human HaCaT cell line. Cancer Res., 51, 4402-4409.
3. BURKE TG AND MI Z. (1994). The structural basis of camptothecin interactions with human serum albumin: impact on drug stability. J. Med. Chem., 37, 40-46.
4. CIOCCA DR, CLARK GM, TANDON AK, FUQUA SA, WELCH WJ AND MCGUIRE WL. (1993). Heat shock protein hsp70 in patients with axillary lymph node-negative breast cancer: prognostic implications. J. Natl Cancer Inst., 85, 570-574.
5. ELLEDGE RM, CLARK GM, FUQUA SA, YU YY AND ALLRED DC. (1994). p53 protein accumulation detected by five different antibodies: relationship to prognosis and heat shock protein 70 in breast cancer. Cancer Res., 54, 3752-3757.
6. FUJITA F, FUJITA M AND SAKAMOTO Y. (1994a). [Acquired resistance and cross-resistance of gemcitabine to cisplatin or vindesine in human lung cancer xenografted in nude mice]. Gan To Kagaku Ryoho, 21, 2749-2755.
7. FUJITA M, FUJITA F, INABA H AND TAGUCHI T. (1994b). [Antitumor activity of LY 188011, a new deoxycytidine analog, against human cancers xenografted into nude mice]. Gan To Kagaku Ryoho, 21, 517-523.
8. FUQUA SA, BENEDIX MG, KRIEG S, WENG CN, CHAMNESS GC AND OESTERREICH S. (1994a). Constitutive overexpression of the 27,000 dalton heat shock protein in late passage human breast cancer cells. Breast Cancer Res. Treat., 32, 177-186.
9. FUQUA SA, OESTERREICH S, HILSENBECK SG, VON HOFF DD, ECKARDT J AND OSBORNE CK. (1994b). Heat shock proteins and drug resistance. Breast Cancer Res. Treat., 32, 67-71.
10. GETHING MJ AND SAMBROOK J. (1992). Protein folding in the cell. Nature, 355, 33-45.
11. HAHN G AND LI GC. (1990). Thermotolerance, thermoresistance and thermosensitation. In Stress Protein in Biology and Medicine RI Morimoto, A Tissiere and C Georgopoulos (eds). Cold Spring Harbour Laboratory Press: Cold Spring Harbour, NY.
12. HOSOKAWA N, HIRAYOSHI K, KUDO H, TAKECHI H, AOIKE A, KAWAIK AND NAGATA K. (1992). Inhibition of the activation of heat shock factor in vivo and in vitro by flavonoids. Mol. Cell. Biol., 12, 3490-3498.
13. HUNT C AND MORIMOTO RL. (1985). Conserved features of eukaryotic hsp70 genes revealed by comparison with the nucleotide sequence of human hsp70. Proc. Natl Acad. Sci. USA, 82, 6455-6459.
14. JÄÄTTELÄ M, WISSING D, BAUER PA AND LI GC. (1992). Major heat shock protein hsp70 protects tumor cells from tumor necrosis factor cytotoxicity. EMBO J, 11, 3507-3512.
15. 2 cell cycle arrest. Biochem. Biophys. Res. Commun. (in press).
16. LARSON JS, SCHUETZ TJ AND KINGSTON RE. (1988). Activation in vitro of sequence-specific DNA binding by a human regulatory factor. Nature, 335, 372-375.
17. LEE YJ, ERDOS G, HOU ZZ, KIM SH, KIM JH, CHO JM AND CORRY PM. (1994). Mechanism of quercetin-induced suppression and delay of heat shock gene expression and thermotolerance development in HT-29 cells. Mol. Cell. Biochem., 137, 141-154.
18. LINDQUIST S AND CRAIG EA. (1988). The heat shock proteins. Annu. Rev. Genet., 22, 631-677.
19. MORIMOTO RI, JURIVICH DA, KROEGER PE, MATHUR SK, MURPHY SP, NAKAI A SARGE K, ABRAVAYA K AND SISTONEN LT. (1994). Regulation of heat shock gene transcription by a family of heat shock factors. In The Biology of Heat Shock Proteins and Molecular Chaperones RI Morimoto, A Tissiere and C Georgopoulos (eds) p. 417. Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY.
20. NAGAI N, NAKAI A AND NAGATA K. (1995). Quercetin suppresses heat shock response by down regulation of HSF1. Biochem. Biophys. Res. Commun., 208, 1099-1105.
21. ÖSTERREICH S, WENG C-N, QIU M, HILSENBECK SG, OSBORNE CK AND FUQUA SAW. (1993). The small heat shock protein hsp27 is correlated with growth and drug resistance in human breast cancer cell lines. Cancer Res., 53, 4443-4448.
22. PARSELL DA AND LINDQUIST S. (1994). Heat shock proteins and stress tolerance. In The Biology of Heat Shock Proteins and Molecular Chaperones RI Morimoto, A Tissiere and C Georgopoulos (eds) p. 457. Cold Spring Harbour Laboratory Press: Cold Spring Harbor, NY.
23. RUIZ VAN HAPEREN VW AND PETERS GJ. (1994). New targets for pyrimidine antimetabolites for the treatment of solid tumours. 2: Deoxycytidine kinase. Pharmacol. World Sci., 16, 104-112.
24. SCHRODER H, LANGER T, HARTL FU AND BUKAU B. (1993). DnaK, DnaJ and GrpE form a cellular chaperone machinery capable of repairing heat-induced protein damage. EMBO J., 12, 4137-4144.
25. SIMON MM, ARAGANE Y, SCHWARZ A, LUGER TA AND SCHWARZ T. (1994). UVB light induces nuclear factor kappa B (NF kappa B) activity independently from chromosomal DNA damage in cell-free cytosolic extracts. J. Invest. Dermatol., 102, 422-427.
26. SIMON MM, REIKERSTORFER A, SCHWARZ A, KRONE C, LUGER TA, JÄÄTTELÄ M AND SCHWARZ T. (1995). Heat shock protein 70 overexpression affects the response to ultraviolet light in murine fibroblasts. Evidence for increased cell viability and suppression of cytokine release. J. Clin. Invest., 95, 926-933.
27. SINHA BK. (1995). Topoisomerase inhibitors. A review of their therapeutic potential in cancer. Drugs, 49, 11-19.
28. SKOWYRA D, GEORGOPOULOS C AND ZYLICZ M. (1990). The E.coli DnaK gene product, the hsp70 homolog, can reactivate heat inactivated RNA polymerase in an ATP hydrolysis dependent manner. Cell, 62, 939-944.
29. SUZUKI K AND WATANABE M. (1994). Modulation of cell growth and mutation induction by introduction of the expression vector of human hsp70 gene. Exp. Cell. Res., 215, 75-81.